Investors with an interest in Medical Services stocks have likely encountered both Bausch + Lomb (BLCO) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Smartleaf Asset Management LLC lifted its stake in Danaher Corporation (NYSE: DHR) by 37.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,754 shares of the conglomerate's stock after purchasing an additional 2,397 shares during the quarter.
Candriam S.C.A. cut its stake in shares of Danaher Corporation (NYSE: DHR) by 1.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 444,856 shares of the conglomerate's stock after selling 7,077 shares during the period. Candriam S.C.A. owned approximately 0.06% of Danaher
Oppenheimer Asset Management Inc. boosted its holdings in shares of Danaher Corporation (NYSE: DHR) by 2.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 163,134 shares of the conglomerate's stock after purchasing an additional 4,350 shares during the
Envestnet Asset Management Inc. increased its stake in shares of Danaher Corporation (NYSE: DHR) by 1.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,379,654 shares of the conglomerate's stock after purchasing an additional 23,690 shares during
Stock News Amazon lifts 2026 capex to ~$200B: Amazon (AMZN) posted a Q4 EPS miss but revenue beat and guided 2026 capital expenditures to about $200 billion, pr
Border to Coast Pensions Partnership Ltd boosted its holdings in shares of Danaher Corporation (NYSE: DHR) by 31.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 204,350 shares of the conglomerate's stock after acquiring an additional 48,437
Atlantic Union Bankshares Corp lifted its position in Danaher Corporation (NYSE: DHR) by 3.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,015 shares of the conglomerate's stock after acquiring an additional 2,291 shares during the quarter. Atlantic
UMB Bank n.a. reduced its stake in Danaher Corporation (NYSE: DHR) by 10.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,452 shares of the conglomerate's stock after selling 4,940 shares during the quarter. UMB Bank n.a.'s
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher (NYSE: DHR) closed 2025 with what management described as a "strong finish" and better-than-expected performance across its portfolio, driven by continued strength in bioprocessing and improving momentum in diagnostics and life sciences. On the company's fourth-quarter earnings call, President and CEO Rainer Blair said disciplined execution helped Danaher exceed its expectations for margins, earnings, and
Sales: $24.6 billion for the full year 2025; $6.8 billion in Q4 2025.Core Revenue Growth: 2% for the full year 2025; 2.5% in Q4 2025.Adjusted Operating Profit
DHR beats Q4 estimates as sales rise 4.5%, driven by strength across Life Sciences, Diagnostics and Biotech, and issued upbeat 2026 earnings guidance.
Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Danaher Corp (NYSE: DHR) on Wednesday reported fourth-quarter 2025 sales of $6.84 billion, up 4.5% year-over-year, beating the consensus of $6.81 billion.
Danaher (DHR) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.14 per share a year ago.
Life sciences firm Danaher Corp forecast annual profit largely in line with Wall Street estimates on Wednesday and beat fourth-quarter profit and revenue expectations, as improving conditions in the pharmaceutical market and reduced policy uncertainties offset weakness in academic research funding.
WASHINGTON, Jan. 28, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.
Guru Stock PicksChuck Royce has made the following transactions:Reduce in HIFS by 5.13%Add in DSP by 72.29%New position in ANDGStock News Social media addiction